Skip to main content

Animations

MJFF Publications

6301 - 6310 of 8715 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2022
  • 2022
  • 2024
  • 2023
  • 2023
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2303789120
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Membrane remodeling properties of the Parkinson’s disease protein LRRK2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2309698120
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Long-term trajectories of ambulatory impairment in multiple sclerosis
    Journal Name: Multiple Sclerosis Journal
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/13524585231187521
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Subcellular proteomics of dopamine neurons in the mouse brain
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.70921
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian mice
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.75253
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-024-00819-7
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Patient-specific models link neurotransmitter receptor mechanisms with motor and visuospatial axes of Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-41677-w
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Neurophysiological signatures of cortical micro-architecture
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-41689-6
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Single-cell transcriptomic and proteomic analysis of Parkinson’s disease brains
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abo1997
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Head-Up Tilt Sleeping to Treat Orthostatic Intolerance in a Patient with Advanced Parkinson’s Disease: A Case Report
    Journal Name: Case Reports in Neurology
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1159/000541424
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.